Anterior urethral tumors occur in approximately 10% of male patients f
ollowing cystectomy for bladder cancer. Prostate stromal involvement b
y the primary transitional cell carcinoma is the greatest risk factor
predicting urethral recurrence. Cytologic screening of the retained ur
ethra identifies most patients with recurrent disease at a curable sta
ge. Total urethrectomy remains the procedure of choice for identified
urethral recurrence.